In the latest trading session, Medtronic (MDT) closed at $88.58, marking a +1.04% move from the previous day. This change outpaced the S&P 500's 0.07% loss on the day. Elsewhere, the Dow saw a ...

Among Medtronic’s other businesses, cardiovascular revenue increased 6.6% to $3.34 billion, neuroscience revenue rose 2.9% to $2.62 billion and medical surgical revenue edged up 0.6% to $2.21 ...

Medical-device maker Medtronic MDT-0.13 % decrease; red down pointing triangle plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a ...

Medtronic in 2015 acquired the brand’s parent, Covidien, for $49.9 billion. Du, the former Medtronic ventilation executive, is now the CEO of ventilator maker Nihon Kohden OrangeMed.

Medtronic, which employs about 10,000 people in Minnesota, reported an adjusted net profit of $1.62 billion on $8.4 billion in sales for its second quarter, which ended Oct. 25.

Medtronic will spin off its $2.8B diabetes unit into a new public company, focusing on high-margin growth markets in medical technology. Minneapolis/St. Paul Business Journal Select a City ...

Medtronic, a global healthcare technology company, announced that MiniMed is the name for the planned new diabetes company following the intended separation. The name honors the company's roots ...

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision.

STAT spoke to Medtronic CEO Geoff Martha about the company’s challenges in the diabetes and renal denervation markets, as well as his broader vision for teasing out innovative products.

Medtronic stock (NYSE: MDT) is down 9% in a week, underperforming the broader markets, with the S&P500 up 0.4%. Although the company posted upbeat Q1 results last week, the stock has declined due ...

Medtronic’s adjusted third-quarter profit tops analyst estimates but its surgical-products revenue dips on temporary inventory issue Last Updated: Feb. 18, 2025 at 12:26 p.m. ET First Published ...

Trefis estimates Medtronic’s Q4 fiscal 2023 total revenues to be around $8.2 billion, reflecting a low single-digit y-o-y rise but marginally below the $8.3 billion consensus estimate.